文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

赣州ART患者HIV CRF01_AE、CRF07_BC和CRF08_BC耐药突变分布特征

Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该研究纳入赣州截至2020年8月31日接受ART的患者,对病毒学失败者扩增HIV pol全长序列,用斯坦福HIVdb分析耐药突变与药物敏感性。2204例中279例病毒学失败,211条序列成功扩增,CRF08_BC、CRF01_AE和CRF07_BC最常见,突变频率分别为44.9%、52.7%和35.2%。三种亚型耐药突变分布不一致,CRF08_BC的NRTI突变比例较高但NRTI和NNRTI耐药频率较低。

要点

  • 2204例ART患者中279例病毒学失败,211条序列成功扩增。
  • 三种主要亚型最常见耐药突变为K103N和M184V。
  • CRF08_BC的NRTI突变比例较高,NRTI和NNRTI耐药频率较低。

核心结论

  • HIV CRF01_AE、CRF07_BC和CRF08_BC的耐药突变分布特征不一致,选择抗逆转录病毒策略、研发新药和控制含耐药突变毒株时应加以考虑。

研究设计与样本

  • 研究纳入赣州截至2020年8月31日接受ART的患者,对病毒学失败者扩增HIV pol基因全长序列,使用斯坦福大学HIV耐药数据库HIVdb程序分析耐药突变和抗逆转录病毒敏感性。

主要发现

  • 2204例接受ART患者中279例病毒学失败。
  • 211条成功扩增序列中鉴定出9种HIV亚型,CRF08_BC占37.0%、CRF01_AE占26.1%、CRF07_BC占25.6%。
  • 三种亚型突变频率分别为CRF08_BC 44.9%(35/78)、CRF01_AE 52.7%(29/55)、CRF07_BC 35.2%(19/54)。
  • 三种亚型最常见耐药突变为K103N和M184V,M41L、D67N、K70R、K101E、V106M、Y181C、K219E、H221Y和N348I突变频率在亚型间明显不同。
  • 三种亚型对奈韦拉平、依非韦伦、拉米夫定和恩曲他滨的耐药最常见;CRF08_BC的NRTI突变比例较高,NRTI和NNRTI耐药频率较低。

临床怎么用

  • 在赣州等CRF01_AE、CRF07_BC和CRF08_BC流行区,选择抗逆转录病毒方案时应考虑亚型特异的耐药突变分布特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Drug resistance mutation (DRM)-associated virological failure has become a critical issue for ART and the elimination of HIV. OBJECTIVES: To investigate the distribution characteristics of DRMs of HIV CRF01_AE, CRF07_BC and CRF08_BC, the predominant subtypes in China. METHODS: Patients receiving ART up to 31 August 2020 in Ganzhou in China were recruited. Full-length sequences of the HIV pol gene were amplified from patients with virological failure. DRMs and antiretroviral susceptibility were explored using the Stanford University HIV Drug Resistance Database HIVdb Program. RESULTS: Overall, 279 of 2204 patients under ART were found to have virological failure. Nine HIV subtypes were identified among 211 sequences that were amplified successfully and CRF08_BC (37.0%), CRF01_AE (26.1%) and CRF07_BC (25.6%) were the most prevalent, with mutation frequencies of 44.9% (35/78), 52.7% (29/55) and 35.2% (19/54), respectively. The most common DRMs of these three subtypes were K103N and M184V, while the mutation frequencies of M41L, D67N, K70R, K101E, V106M, Y181C, K219E, H221Y and N348I were obviously different among subtypes. The resistance levels and frequencies for antiretroviral drugs for these three subtypes were similar and resistances to nevirapine, efavirenz, lamivudine and emtricitabine were the most frequently observed. Compared with CRF01_AE and CRF07_BC, CRF08_BC had higher proportions of DRMs for NRTIs and lower frequencies of resistance to NRTIs and NNRTIs. CONCLUSIONS: The distribution characteristics of DRMs of HIV CRF01_AE, CRF07_BC and CRF08_BC were inconsistent and should be considered when selecting antiretroviral strategies, developing new drugs and controlling HIV strains containing DRMs.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Xie YN, Zhu FX, Zhong YT, et al. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China. J Antimicrob Chemother. 2021. PMID: 34402512. doi:10.1093/jac/dkab296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。